KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis

被引：85

作者：

Yuan, Peng ^{[1
,2
]}

He, Xiao-Hong ^{[1
,2
]}

Rong, Ye-Fei ^{[3
]}

Cao, Jing ^{[4
]}

Li, Yong ^{[5
]}

Hu, Yun-Ping ^{[6
]}

Liu, Yingbin ^{[6
]}

Li, Dangsheng ^{[7
]}

Lou, Wenhui ^{[3
]}

Liu, Mo-Fang ^{[1
,2
]}

机构：

[1] Univ Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol, Ctr RNA Res, Shanghai, Peoples R China

[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl, Shanghai, Peoples R China

[3] Zhong Shan Hosp, Dept Pancreat Surg, 180 Fenglin Rd, Shanghai 200032, Peoples R China

[4] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China

[5] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA

[6] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai, Peoples R China

[7] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Informat Ctr Life Sci, Shanghai, Peoples R China

来源：

CANCER RESEARCH | 2017年 / 77卷 / 01期

基金：

中国国家自然科学基金;

关键词：

NF-KAPPA-B; BREAST-CANCER; DUCTAL ADENOCARCINOMA; TRANSCRIPTION FACTOR; MICRORNA EXPRESSION; SKELETAL MYOGENESIS; CELL INVASION; INFLAMMATION; KRAS; YY1;

D O I：

10.1158/0008-5472.CAN-16-1898

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

KRAS activation occurring in more than 90% of pancreatic ductal adenocarcinomas (PDAC) drives progression and metastasis, but the underlying mechanisms involved in these processes are still poorly understood. Here, we show how KRAS acts through inflammatory NF-B-k signaling to activate the transcription factor YY1, which represses expression of the tumor suppressor gene miR-489. In PDAC cells, repression of miR-489 by KRAS signaling inhibited migration and metastasis by targeting the extracellular matrix factors ADAM9 and MMP7. miR-489 downregulation elevated levels of ADAM9 and MMP7, thereby enhancing the migration and metastasis of PDAC cells. Together, our results establish a pivotal mechanism of PDAC metastasis and suggest miR-489 as a candidate therapeutic target for their attack. (C) 2016 AACR.

引用

页码：100 / 111

页数：12

共 50 条

[11] The Discovery of MMP7 Inhibitors Exploiting a Novel Selectivity Trigger [J].

Edman, Karl ;

Furber, Mark ;

Hemsley, Paul ;

Johansson, Cristian ;

Pairaudeau, Garry ;

Petersen, Jens ;

Stocks, Michael ;

Tervo, Anu ;

Ward, Alison ;

Wells, Edward ;

Wissler, Lisa .

CHEMMEDCHEM, 2011, 6 (05) :769-773

[12] Cluster analysis and display of genome-wide expression patterns [J].

Eisen, MB ;

Spellman, PT ;

Brown, PO ;

Botstein, D .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14863-14868

[13] Selective inhibition of NF-κB attenuates the severity of cerulein-induced acute pancreatitis [J].

Ethridge, RT ;

Hashimoto, K ;

Chung, DH ;

Ehlers, RA ;

Rajaraman, S ;

Evers, BM .

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2002, 195 (04) :497-505

[14] Upregulation of miR-21 by Ras in vivo and its role in tumor growth [J].

Frezzetti, D. ;

De Menna, M. ;

Zoppoli, P. ;

Guerra, C. ;

Ferraro, A. ;

Bello, A. M. ;

De Luca, P. ;

Calabrese, C. ;

Fusco, A. ;

Ceccarelli, M. ;

Zollo, M. ;

Barbacid, M. ;

Di Lauro, R. ;

De Vita, G. .

ONCOGENE, 2011, 30 (03) :275-286

[15] Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression [J].

Fukuda, Akihisa ;

Wang, Sam C. ;

Morris, John P. ;

Folias, Alexandra E. ;

Liou, Angela ;

Kim, Grace E. ;

Akira, Shizuo ;

Boucher, Kenneth M. ;

Firpo, Matthew A. ;

Mulvihill, Sean J. ;

Hebrok, Matthias .

CANCER CELL, 2011, 19 (04) :441-455

[16] Transcription factor YY1: structure, function, and therapeutic implications in cancer biology [J].

Gordon, S ;

Akopyan, G ;

Garban, H ;

Bonavida, B .

ONCOGENE, 2006, 25 (08) :1125-1142

[17] Immunity, Inflammation, and Cancer [J].

Grivennikov, Sergei I. ;

Greten, Florian R. ;

Karin, Michael .

CELL, 2010, 140 (06) :883-899

[18] YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress [J].

Grönroos, E ;

Terentiev, AA ;

Punga, T ;

Ericsson, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (33) :12165-12170

[19] ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma [J].

Grützmann, R ;

Lüttges, J ;

Sipos, B ;

Ammerpohl, O ;

Dobrowolski, F ;

Alldinger, I ;

Kersting, S ;

Ockert, D ;

Koch, R ;

Kalthoff, H ;

Schackerts, HK ;

Saeger, HD ;

Klöppel, G ;

Pilarsky, C .

BRITISH JOURNAL OF CANCER, 2004, 90 (05) :1053-1058

[20] Gene expression profiles of microdissected pancreatic ductal adenocarcinoma [J].

Grützmann, R ;

Foerder, M ;

Alldinger, I ;

Staub, E ;

Brümmendorf, T ;

Röpcke, S ;

Li, XZ ;

Kristiansen, G ;

Jesnowski, R ;

Sipos, B ;

Löhr, M ;

Lüttges, J ;

Ockert, D ;

Klöppel, G ;

Saeger, HD ;

Pilarsky, C .

VIRCHOWS ARCHIV, 2003, 443 (04) :508-517

← 1 2 3 4 5 →